StockFacets
About
Sign-up
Sign-in
Earnings Calendar
Prices are updated after-hours
Published
Previous years
8534
This month
114
This week
46
This year
538
Today
5
Yesterday
11
Publishing Date
2023 - 12 - 12
19
2023 - 12 - 11
25
2023 - 10 - 24
18
2023 - 10 - 23
18
2023 - 09 - 26
18
2023 - 09 - 11
19
2023 - 06 - 05
27
2023 - 05 - 25
27
2023 - 04 - 26
19
2023 - 02 - 13
18
2022 - 12 - 12
18
2022 - 12 - 08
21
2022 - 10 - 26
18
2022 - 09 - 08
18
2022 - 06 - 22
19
2022 - 06 - 06
21
2022 - 05 - 31
18
2022 - 05 - 26
23
2022 - 05 - 23
25
2022 - 03 - 15
20
2022 - 03 - 14
20
2022 - 03 - 01
22
2022 - 02 - 28
22
2022 - 01 - 24
19
2022 - 01 - 18
20
2022 - 01 - 04
18
2021 - 12 - 16
18
2021 - 12 - 14
22
2021 - 12 - 13
37
2021 - 12 - 09
25
2021 - 12 - 06
33
2021 - 12 - 01
20
2021 - 11 - 30
18
2021 - 11 - 15
24
2021 - 11 - 08
22
2021 - 11 - 03
20
2021 - 10 - 28
21
2021 - 10 - 27
18
2021 - 10 - 25
21
2021 - 10 - 20
18
2021 - 10 - 18
18
2021 - 10 - 14
19
2021 - 10 - 13
22
2021 - 10 - 07
22
2021 - 09 - 29
19
2021 - 09 - 13
28
2021 - 09 - 09
19
2021 - 09 - 08
20
2021 - 07 - 27
19
2021 - 07 - 15
18
2021 - 07 - 06
19
2021 - 06 - 28
26
2021 - 06 - 24
18
2021 - 06 - 23
24
2021 - 06 - 11
18
2021 - 06 - 08
18
2021 - 06 - 07
30
2021 - 05 - 12
18
2021 - 04 - 12
21
2021 - 03 - 18
19
Sector
Administrative and support and waste management and remediation services
3
Arts, entertainment, and recreation
4
Commercial services
107
Communications
108
Consumer durables
41
Consumer non-durables
30
Consumer services
24
Distribution services
44
Electronic technology
165
Energy minerals
10
Finance
202
Finance and insurance
3
Health care and social assistance
15
Health services
105
Health technology
5690
Industrial services
41
Information
20
Manufacturing
560
Mining, quarrying, and oil and gas extraction
18
Miscellaneous
3
N/a
222
Non-energy minerals
32
Process industries
140
Producer manufacturing
447
Professional, scientific, and technical services
241
Real estate and rental and leasing
8
Retail trade
57
Technology services
165
Transportation
41
Transportation and warehousing
25
Utilities
8
Wholesale trade
9
Tags
Alliances
104
Als
190
Alzheimer's
104
Alzheimer’s
151
Antibody
100
Application
135
Approval
167
Biopharma
169
Biotech
133
Biotech-bay
105
Biotech-beach
115
Cancer
788
Cell
122
China
108
Clearance
115
Clinical trials
130
Clinical-trials-phase-i
219
Clinical-trials-phase-ii
1195
Clinical-trials-phase-iii
903
Collaboration
137
Conference
350
Covid
315
Covid-19
237
Deadline
140
Disease
540
Drug
219
Enroll
318
Europe
134
Events
123
Fda
374
Genetown
143
Growth
146
Iot
125
Meeting
231
N/a
4279
Ongoing
249
Pharm-country
156
Pharma
157
Pharmaceuticals
257
Phase 1
750
Phase 1b
124
Phase 2
1215
Phase 2b
438
Phase 3
854
Positive
947
Potential
113
Presentation
218
Publication
115
Report
98
Research
595
Results
1020
Study
296
Therapeutics
876
Therapy
362
Topline
407
Treatment
1037
Trial
6821
Trials
571
Update
148
Vaccine
283
Entities
4d molecular therapeutics inc
24
Abb ltd
72
Abbvie inc.
62
Actinium pharmaceuticals, inc.
28
Aldeyra therapeutics, inc.
38
Alnylam pharmaceuticals, inc.
38
Alterity therapeutics limited
26
Altra industrial motion corp.
23
Amgen inc.
25
Anavex life sciences corp.
24
Arcutis biotherapeutics, inc.
29
Arrival
26
Arrowhead pharmaceuticals, inc.
23
Astellas pharma inc
26
Astrazeneca plc
64
Beigene, ltd.
35
Biogen inc.
23
Biovie inc.
28
Bioxcel therapeutics, inc.
26
Bristol-myers squibb company
73
Clearside biomedical, inc.
24
Clene inc
25
Cnh industrial n.v.
69
Cybin inc
26
Cytokinetics, incorporated
29
Dynavax technologies corporation
28
Eli lilly and company
161
Enlivex therapeutics ltd.
25
Exelixis, inc.
28
Fortress biotech, inc.
41
Gates industrial corporation plc
25
Gilead sciences, inc.
48
Global industrial co
38
Honeywell international inc.
53
Horizon therapeutics public limited company
46
I-mab
34
Icon plc
43
Immix biopharma, inc.
26
Immutep limited
34
Incyte corporation
49
Johnson & johnson
203
Medtronic plc
25
Merck & company, inc.
72
Moleculin biotech, inc.
34
Novartis ag
34
Novo nordisk a/s
41
Ocugen, inc.
27
Orange
91
Pds biotechnology corporation
24
Pfizer, inc.
61
Plus therapeutics, inc.
35
Regeneron pharmaceuticals, inc.
44
Regenxbio inc.
29
Sanofi
310
Sellas life sciences group, inc.
24
Sorrento therapeutics, inc.
38
Stag industrial, inc.
32
Takeda pharmaceutical company limited
56
Tg therapeutics, inc.
27
Thermo fisher scientific inc
48
Symbols
ABB
72
ABBV
62
ABLZF
31
ALDX
38
ALNY
38
ALPMF
26
ALPMY
26
AMGN
25
ARQT
29
ARVL
26
ATHE
26
ATNM
28
AVXL
24
AZN
64
BGNE
35
BIVI
28
BMY
73
BTAI
26
CLNN
25
CLSD
24
CNHI
69
CYBN
26
CYTK
29
DVAX
28
ENLV
25
EXEL
28
FBIO
41
FDMT
24
FNCTF
91
GIC
38
GILD
48
GTES
25
HON
53
HZNP
46
ICLR
43
IMAB
34
IMMP
34
IMMX
26
INCY
49
JNJ
203
LLY
161
MBRX
34
MDT
25
MRK
72
NVO
41
NVS
34
NVSEF
24
OCGN
27
PDSB
24
PFE
61
PSTV
35
REGN
44
RGNX
29
SNY
310
SNYNF
245
SRNE
38
STAG
32
TAK
56
TGTX
27
TMO
48
Exchanges
Amex
157
Nasdaq
7006
Nyse
1914
Crawled Date
2023 - 12 - 12
21
2023 - 12 - 11
23
2023 - 10 - 23
18
2023 - 09 - 26
18
2023 - 09 - 11
19
2023 - 06 - 05
26
2023 - 05 - 25
28
2023 - 01 - 09
18
2022 - 12 - 12
19
2022 - 12 - 08
22
2022 - 11 - 03
18
2022 - 10 - 26
18
2022 - 06 - 22
18
2022 - 06 - 06
22
2022 - 05 - 23
25
2022 - 03 - 15
20
2022 - 03 - 14
20
2022 - 03 - 01
22
2022 - 02 - 28
22
2022 - 01 - 24
18
2022 - 01 - 04
18
2021 - 12 - 16
18
2021 - 12 - 14
21
2021 - 12 - 13
36
2021 - 12 - 09
24
2021 - 12 - 06
33
2021 - 12 - 01
20
2021 - 11 - 30
18
2021 - 11 - 16
18
2021 - 11 - 15
23
2021 - 11 - 08
22
2021 - 11 - 03
19
2021 - 10 - 28
21
2021 - 10 - 27
18
2021 - 10 - 25
20
2021 - 10 - 20
18
2021 - 10 - 14
19
2021 - 10 - 13
22
2021 - 10 - 07
22
2021 - 09 - 29
19
2021 - 09 - 13
29
2021 - 09 - 09
19
2021 - 09 - 08
20
2021 - 07 - 27
18
2021 - 07 - 15
18
2021 - 07 - 06
20
2021 - 06 - 28
26
2021 - 06 - 23
25
2021 - 06 - 11
18
2021 - 06 - 07
30
2021 - 05 - 25
17
2021 - 05 - 12
18
2021 - 04 - 15
18
2021 - 04 - 12
20
2021 - 03 - 18
20
2020 - 12 - 15
17
2020 - 12 - 10
17
2020 - 12 - 09
23
2020 - 12 - 03
24
2020 - 12 - 01
24
Crawled Time
00:00
172
00:20
52
01:00
99
02:00
31
03:00
24
03:10
4
04:00
27
04:20
23
05:00
47
06:00
62
07:00
97
08:00
63
08:20
9
09:00
73
09:33
4
10:00
96
10:08
8
11:00
468
11:03
4
12:00
1147
12:01
13
12:03
20
12:07
4
12:15
135
12:20
210
12:30
178
12:39
4
13:00
901
13:01
16
13:03
15
13:05
6
13:07
5
13:15
103
13:20
200
13:30
197
13:35
7
14:00
705
14:01
10
14:03
6
14:04
4
14:15
58
14:20
108
14:30
113
15:00
440
15:15
35
15:20
48
15:30
92
16:00
257
16:20
61
17:00
264
18:00
197
19:00
189
20:00
261
20:20
53
21:00
332
22:00
330
22:01
6
22:08
6
22:10
5
23:00
220
Source
alteritytherapeutics.com
16
alzamend.com
3
brainsway.com
2
contravir.com
5
firstcobalt.com
5
investor.assemblybio.com
4
investors.biomarin.com
2
ir.akerotx.com
2
ir.anaptysbio.com
3
ir.auriniapharma.com
2
ir.benitec.com
2
ir.biolinerx.com
6
ir.hoththerapeutics.com
5
ir.kalvista.com
3
ir.opgen.com
2
ir.radiuspharm.com
3
ir.vaccinex.com
3
ir.viveve.com
6
ir.zynerba.com
2
jaguarhealth.gcs-web.com
5
mindmed.co
6
neurosense.investorroom.com
6
ocutx.gcs-web.com
3
renovorx.com
2
spacfeed.com
13
velodynelidar.com
9
www.4dpharmaplc.com
6
www.achievelifesciences.com
5
www.adnas.com
4
www.agtc.com
5
www.akerotx.com
3
www.allogene.com
2
www.anaptysbio.com
3
www.anavex.com
4
www.aquestive.com
4
www.athira.com
3
www.atyrpharma.com
3
www.balchem.com
2
www.biolase.com
2
www.biospace.com
4191
www.brainsway.com
3
www.celyad.com
3
www.fatetherapeutics.com
6
www.fda.gov
7
www.fsdpharma.com
5
www.globenewswire.com
2453
www.hancockjaffe.com
3
www.igcinc.us
7
www.inovio.com
8
www.inventivapharma.com
5
www.nantkwest.com
8
www.novocure.com
5
www.nurixtx.com
5
www.ppdi.com
14
www.prnewswire.com
1519
www.stagindustrial.com
21
www.ucore.com
3
www.veeva.com
3
www.vynetherapeutics.com
4
www.zynerba.com
3
Sort by:
after hours % change
|
delayed % change
|
gain open
|
gain high
|
gain close
|
publishing date
(GMT-12:00) International Date Line West
(GMT-11:00) American Samoa
(GMT-11:00) Midway Island
(GMT-10:00) Hawaii
(GMT-09:00) Alaska
(GMT-08:00) Pacific Time (US & Canada)
(GMT-08:00) Tijuana
(GMT-07:00) Arizona
(GMT-07:00) Chihuahua
(GMT-07:00) Mazatlan
(GMT-07:00) Mountain Time (US & Canada)
(GMT-06:00) Central America
(GMT-06:00) Central Time (US & Canada)
(GMT-06:00) Guadalajara
(GMT-06:00) Mexico City
(GMT-06:00) Monterrey
(GMT-06:00) Saskatchewan
(GMT-05:00) Bogota
(GMT-05:00) Eastern Time (US & Canada)
(GMT-05:00) Indiana (East)
(GMT-05:00) Lima
(GMT-05:00) Quito
(GMT-04:00) Atlantic Time (Canada)
(GMT-04:00) Caracas
(GMT-04:00) Georgetown
(GMT-04:00) La Paz
(GMT-04:00) Puerto Rico
(GMT-04:00) Santiago
(GMT-03:30) Newfoundland
(GMT-03:00) Brasilia
(GMT-03:00) Buenos Aires
(GMT-03:00) Greenland
(GMT-03:00) Montevideo
(GMT-02:00) Mid-Atlantic
(GMT-01:00) Azores
(GMT-01:00) Cape Verde Is.
(GMT+00:00) Casablanca
(GMT+00:00) Dublin
(GMT+00:00) Edinburgh
(GMT+00:00) Lisbon
(GMT+00:00) London
(GMT+00:00) Monrovia
(GMT+00:00) UTC
(GMT+01:00) Amsterdam
(GMT+01:00) Belgrade
(GMT+01:00) Berlin
(GMT+01:00) Bern
(GMT+01:00) Bratislava
(GMT+01:00) Brussels
(GMT+01:00) Budapest
(GMT+01:00) Copenhagen
(GMT+01:00) Ljubljana
(GMT+01:00) Madrid
(GMT+01:00) Paris
(GMT+01:00) Prague
(GMT+01:00) Rome
(GMT+01:00) Sarajevo
(GMT+01:00) Skopje
(GMT+01:00) Stockholm
(GMT+01:00) Vienna
(GMT+01:00) Warsaw
(GMT+01:00) West Central Africa
(GMT+01:00) Zagreb
(GMT+01:00) Zurich
(GMT+02:00) Athens
(GMT+02:00) Bucharest
(GMT+02:00) Cairo
(GMT+02:00) Harare
(GMT+02:00) Helsinki
(GMT+02:00) Jerusalem
(GMT+02:00) Kaliningrad
(GMT+02:00) Kyiv
(GMT+02:00) Pretoria
(GMT+02:00) Riga
(GMT+02:00) Sofia
(GMT+02:00) Tallinn
(GMT+02:00) Vilnius
(GMT+03:00) Baghdad
(GMT+03:00) Istanbul
(GMT+03:00) Kuwait
(GMT+03:00) Minsk
(GMT+03:00) Moscow
(GMT+03:00) Nairobi
(GMT+03:00) Riyadh
(GMT+03:00) St. Petersburg
(GMT+03:30) Tehran
(GMT+04:00) Abu Dhabi
(GMT+04:00) Baku
(GMT+04:00) Muscat
(GMT+04:00) Samara
(GMT+04:00) Tbilisi
(GMT+04:00) Volgograd
(GMT+04:00) Yerevan
(GMT+04:30) Kabul
(GMT+05:00) Ekaterinburg
(GMT+05:00) Islamabad
(GMT+05:00) Karachi
(GMT+05:00) Tashkent
(GMT+05:30) Chennai
(GMT+05:30) Kolkata
(GMT+05:30) Mumbai
(GMT+05:30) New Delhi
(GMT+05:30) Sri Jayawardenepura
(GMT+05:45) Kathmandu
(GMT+06:00) Almaty
(GMT+06:00) Astana
(GMT+06:00) Dhaka
(GMT+06:00) Urumqi
(GMT+06:30) Rangoon
(GMT+07:00) Bangkok
(GMT+07:00) Hanoi
(GMT+07:00) Jakarta
(GMT+07:00) Krasnoyarsk
(GMT+07:00) Novosibirsk
(GMT+08:00) Beijing
(GMT+08:00) Chongqing
(GMT+08:00) Hong Kong
(GMT+08:00) Irkutsk
(GMT+08:00) Kuala Lumpur
(GMT+08:00) Perth
(GMT+08:00) Singapore
(GMT+08:00) Taipei
(GMT+08:00) Ulaanbaatar
(GMT+09:00) Osaka
(GMT+09:00) Sapporo
(GMT+09:00) Seoul
(GMT+09:00) Tokyo
(GMT+09:00) Yakutsk
(GMT+09:30) Adelaide
(GMT+09:30) Darwin
(GMT+10:00) Brisbane
(GMT+10:00) Canberra
(GMT+10:00) Guam
(GMT+10:00) Hobart
(GMT+10:00) Melbourne
(GMT+10:00) Port Moresby
(GMT+10:00) Sydney
(GMT+10:00) Vladivostok
(GMT+11:00) Magadan
(GMT+11:00) New Caledonia
(GMT+11:00) Solomon Is.
(GMT+11:00) Srednekolymsk
(GMT+12:00) Auckland
(GMT+12:00) Fiji
(GMT+12:00) Kamchatka
(GMT+12:00) Marshall Is.
(GMT+12:00) Wellington
(GMT+12:45) Chatham Is.
(GMT+13:00) Nuku'alofa
(GMT+13:00) Samoa
(GMT+13:00) Tokelau Is.
trial
save search
Two Clinical Trials Identify a Better Way to Target Appropriate Antibiotics for Patients Hospitalized With Pneumonia or Urinary Tract Infection
Published:
2024-04-19
(Crawled : 22:00)
- biospace.com/
FNCTF
|
News
|
$11.0354
-20.84%
320
|
Communications
|
Email alert
Add to watchlist
infection
antibiotics
trials
for
Hepion Pharmaceuticals Initiates Wind-Down Activities in Phase 2b ‘ASCEND-NASH’ Trial
Published:
2024-04-19
(Crawled : 20:00)
- globenewswire.com
HEPA
|
News
|
$2.11
-0.09%
-0.09%
73K
|
Health Technology
|
Email alert
Add to watchlist
pharmaceuticals
trial
Health Canada Approves KEYTRUDA as a first-line treatment for adult patients with locally advanced unresectable or metastatic HER2-negative gastric or gastroesophageal junction (GEJ) adenocarcinoma
Published:
2024-04-19
(Crawled : 13:00)
- biospace.com/
MRK
|
News
|
$125.78
0.44%
0.0%
8.4M
|
Health Technology
|
0.0%
|
O:
0.5%
H:
0.0%
C:
0.0%
health
treatment
for
canada
advanced
keytruda
Ocugen Announces Dosing Completion of Subjects with Geographic Atrophy in Cohort 2 of Phase 1/2 ArMaDa Clinical Trial of OCU410—A Modifier Gene Therapy
Published:
2024-04-19
(Crawled : 11:00)
- globenewswire.com
OCGN
|
News
A
|
$1.315
-0.38%
-0.38%
6.5M
|
Health Technology
|
-13.44%
|
O:
-15.41%
H:
0.0%
C:
0.0%
ocu410
armada
trial
therapy
Clinical Trials Matching Software Market Projected to Reach $832.56 million by 2030 - Exclusive Report by 360iResearch
Published:
2024-04-19
(Crawled : 04:00)
- prnewswire.com
IBM
|
News
|
$181.58
0.06%
-0.32%
3M
|
Technology Services
|
0.0%
|
O:
-0.17%
H:
0.0%
C:
0.0%
report
million
software
reach
trials
market
YS Biopharma Granted Phase I Clinical Trial License of Therapeutic Chronic Hepatitis B Virus Vaccine
Published:
2024-04-18
(Crawled : 19:00)
- biospace.com/
YS
|
News
|
$0.7013
-17.98%
-21.92%
420K
|
n/a
|
-7.45%
|
O:
-7.45%
H:
0.0%
C:
0.0%
hepatitis
vaccine
license
granted
biopharma
virus
trial
Phase 3 SELECT-GCA Study of Upadacitinib (RINVOQ®) Showed Positive Results in Patients With Giant Cell Arteritis
Published:
2024-04-18
(Crawled : 19:00)
- biospace.com/
ABBV
|
$166.41
1.06%
0.0%
5.5M
|
Health Technology
|
0.75%
|
O:
0.75%
H:
0.0%
C:
0.0%
rinvoq
positive
cell
results
study
Calliditas Therapeutics Presents Additional Data Analyses from the Phase 3 NeflgArd trial of Nefecon in Primary IgA Nephropathy at the ISN World Congress of Nephrology 2024
Published:
2024-04-18
(Crawled : 12:00)
- biospace.com/
CALT
|
$17.65
-2.4%
4K
|
Health Technology
|
-3.71%
|
O:
-0.87%
H:
3.58%
C:
-2.86%
nephropathy
congress
world
nefecon
trial
therapeutics
Benitec Biopharma Reports Positive Interim Clinical Trial Data for First OPMD Subject Treated with BB-301 in Phase 1b/2a Study
Published:
2024-04-18
(Crawled : 12:00)
- biospace.com/
BNTC
|
$6.89
1.03%
1.02%
250K
|
Health Technology
|
36.67%
|
O:
5.41%
H:
41.06%
C:
29.66%
bb-301
first
positive
biopharma
for
trial
opmd
study
Cerevel Therapeutics Announces Positive Topline Results for Tavapadon in Phase 3 Adjunctive Trial for People Living with Parkinson’s Disease
Published:
2024-04-18
(Crawled : 11:00)
- globenewswire.com
CERE
|
$42.15
0.02%
0.02%
810K
|
Finance
|
0.78%
|
O:
0.78%
H:
0.0%
C:
0.0%
disease
positive
for
topline
parkinson’s
trial
therapeutics
results
living
Bio-Path Holdings Announces Successful Completion of Higher Dose Second Cohort in Phase 1/1b Clinical Trial of BP1002 in Refractory/Relapsed Acute Myeloid Leukemia (AML) Patients
Published:
2024-04-18
(Crawled : 11:00)
- globenewswire.com
BPTH
|
News
0 d
|
$4.17
-0.71%
-0.96%
2.1M
|
Health Technology
|
34.19%
|
O:
72.84%
H:
41.77%
C:
-22.37%
bp1002
leukemia
trial
Evolus Announces Publication of Safety and Duration Data from Phase 2 Study for “Extra-Strength” 40U Formulation of Jeuveau®
Published:
2024-04-17
(Crawled : 22:00)
- biospace.com/
EOLS
|
$11.49
-0.61%
-0.61%
350K
|
Health Technology
|
-1.49%
|
O:
-1.49%
H:
0.0%
C:
0.0%
jeuveau
publication
for
study
DiaMedica Therapeutics Announces First Patient Dosed in Relaunch of its Pivotal Phase 2/3 ReMEDy2 Trial of DM199 for the Treatment of Acute Ischemic Stroke
Published:
2024-04-17
(Crawled : 22:00)
- biospace.com/
DMAC
|
$2.46
-1.21%
-1.22%
21K
|
Health Technology
|
4.43%
|
O:
4.43%
H:
0.0%
C:
0.0%
dm199
first
stroke
treatment
for
trial
therapeutics
Artiva Biotherapeutics Announces First Patient Dosed in Phase 1 Trial of AlloNK® Cell Therapy Candidate in Lupus Nephritis
Published:
2024-04-17
(Crawled : 15:00)
- biospace.com/
AFMD
|
$5.15
1.58%
1.55%
64K
|
Health Technology
|
-5.59%
|
O:
-2.42%
H:
0.0%
C:
0.0%
allonk
first
candidate
lupus
cell
trial
therapy
Ventus Therapeutics Announces Results from Phase 1 Clinical Trial of VENT-02, a Novel, Orally Administered, Brain-Penetrant NLRP3 Inhibitor
Published:
2024-04-17
(Crawled : 14:00)
- biospace.com/
NVO
|
News
|
$122.71
-0.03%
0.17%
5M
|
Health Technology
|
0.87%
|
O:
1.22%
H:
0.21%
C:
-0.34%
vent-02
trial
therapeutics
results
Immutep Receives Positive Feedback from the Spanish Medicines Agency for Upcoming TACTI-004 Registrational Trial in Metastatic Non-Small Cell Lung Cancer
Published:
2024-04-17
(Crawled : 12:00)
- globenewswire.com
IMMP
|
$2.25
2.27%
2.22%
90K
|
Health Technology
|
-5.58%
|
O:
-6.87%
H:
0.0%
C:
0.0%
tacti-004
lung
positive
cancer
cell
for
trial
NeuroBo Pharmaceuticals Doses First Patient in Its Phase 1 Clinical Trial Evaluating DA-1726 for the Treatment of Obesity
Published:
2024-04-17
(Crawled : 12:00)
- prnewswire.com
NRBO
|
$3.325
-3.34%
-3.46%
21K
|
Health Technology
|
1.76%
|
O:
8.53%
H:
0.0%
C:
-6.23%
da-1726
obesity
first
treatment
pharmaceuticals
for
trial
Evaxion Announces Phase 2 Clinical Trial Update: First Patient Completed Dosing with Personalized Cancer Vaccine EVX-01
Published:
2024-04-17
(Crawled : 12:00)
- globenewswire.com
EVAX
|
$4.2
-0.47%
-0.48%
31K
|
Manufacturing
|
3.69%
|
O:
0.25%
H:
0.0%
C:
0.0%
evx-01
first
vaccine
cancer
trial
Sage Therapeutics Announces Topline Results from Phase 2 PRECEDENT Study of Dalzanemdor (SAGE-718) in the Treatment of Mild Cognitive Impairment in Parkinson’s Disease
Published:
2024-04-17
(Crawled : 12:00)
- biospace.com/
SAGE
|
$13.35
2.42%
2.36%
1.3M
|
Health Technology
|
-17.57%
|
O:
-15.02%
H:
3.55%
C:
-3.01%
sage-718
disease
treatment
topline
parkinson’s
therapeutics
results
study
STAR-T Pivotal Trial Results to Be Featured as a Late-Breaking Presentation at the 2024 American Association for Thoracic Surgery Annual Meeting
Published:
2024-04-17
(Crawled : 11:00)
- globenewswire.com
CTSO
|
$0.8026
0.2%
0.2%
46K
|
Health Technology
|
-2.2%
|
O:
-0.99%
H:
0.0%
C:
0.0%
association
presentation
for
meeting
trial
results
← Previous
1
2
3
4
5
6
7
8
9
…
426
427
Next →
Gainers vs Losers
67%
33%
Top 10 Gainers
AGBA
|
News
|
$1.26
215.0%
68.25%
130M
|
Finance
EGOX
|
$0.0515
43.06%
30.1%
330M
|
OLB
4
|
$0.33
-14.95%
25.53%
840K
|
Technology Services
NVFY
|
$2.77
31.28%
23.83%
33M
|
Consumer Durables
ZCMD
|
$1.87
28.97%
22.46%
31M
|
Commercial Services
RCON
|
$0.1112
13.01%
21.28%
1.7M
|
Distribution Services
INSG
|
$3.03
25.21%
20.13%
330K
|
Electronic Technology
GCTK
|
$0.8191
22.25%
18.2%
190K
|
Manufacturing
WLGS
|
$0.59
18.0%
17.9%
2.3M
|
ASNS
|
$0.828
21.75%
17.86%
18K
|
Your saved searches
Save your searches and get alerts when important news are released.